UZH-Logo

Maintenance Infos

Browse by Creators - Zurich Open Repository and Archive

Navigate back| Up a level
Export as
Number of items: 16.

Janssen, S; Glanzmann, C; Huber, G; Studer, G (2014). Individualized IMRT treatment approach for cervical lymph node metastases of unknown primary. Strahlentherapie und Onkologie, 190(4):386-393.

Studer, G; Linsenmeier, C; Riesterer, O; Najafi, Y; Brown, M; Yousefi, B; Bredell, M; Huber, G; Schmid, S; Studer, S; Zwahlen, R; Rordorf, T; Glanzmann, C (2013). Late term tolerance in head neck cancer patients irradiated in the IMRT era. Radiation Oncology, 8:259.

Huber, G (2013). Surgical oncologist or prophet? Praxis, 102(1):39-44.

Studer, G; Brown, M; Bredell, M; Graetz, K W; Huber, G; Linsenmeier, C; Najafi, Y; Riesterer, O; Rordorf, T; Schmid, S; Glanzmann, C (2012). Follow up after IMRT in oral cavity cancer: update. Radiation Oncology, 7:84.

Fischer, M D; Huber, G; Paquet-Durand, F; Humphries, P; Redmond, T M; Grimm, C; Seeliger, M W (2012). In Vivo Assessment of Rodent Retinal Structure Using Spectral Domain Optical Coherence Tomography. In: LaVail, M M; Ash, J D; Anderson, R G; Hollyfileld, J G; Grimm, C. Retinal Degenerative Diseases. New York: Springer, 489-494.

Lange, C; Caprara, C; Tanimoto, N; Beck, S; Huber, G; Samardzija, M; Seeliger, M; Grimm, C (2011). Retina-specific activation of a sustained hypoxia-like response leads to severe retinal degeneration and loss of vision. Neurobiology of Disease, 41(1):119-130.

Peponi, E; Glanzmann, C; Willi, B; Huber, G; Studer, G (2011). Dysphagia in head and neck cancer patients following intensity modulated radiotherapy (IMRT). Radiation Oncology, 6:1.

Studer, G; Peponi, E; Kloeck, S; Dossenbach, T; Huber, G; Glanzmann, C (2010). Surviving hypopharynx-larynx carcinoma in the era of IMRT. International Journal of Radiation Oncology, Biology and Physics, 77(5):1391-1396.

Sidler, D; Thum, P; Winterhalder, R; Huber, G; Haerle, S K (2010). Undifferentiated carcinoma of nasopharyngeal type (UCNT): a Swiss single-institutional experience during 1990-2005. Swiss Medical Weekly, 140(19-20):273-279.

Huber, G; Heynen, S; Imsand, C; vom Hagen, F; Muehlfriedel, R; Tanimoto, N; Feng, Y; Hammes, H P; Grimm, C; Peichl, L; Seeliger, M W; Beck, S C (2010). Novel rodent models for macular research. PLoS ONE, 5(10):e13403.

Huber, G; Beck, S C; Grimm, C; Sahaboglu-Tekgoz, A; Paquet-Durand, F; Wenzel, A; Humphries, P; Redmond, T M; Seeliger, M W; Fischer, D (2009). Spectral domain optical coherence tomography in mouse models of retinal degeneration. Investigative Ophthalmology and Visual Science, 50(12):5888-5995.

Eichenberger, U; Stöckli, S; Marhofer, P; Huber, G; Willimann, P; Kettner, S C; Pleiner, J; Curatolo, M; Kapral, S (2009). Minimal local anesthetic volume for peripheral nerve block: a new ultrasound-guided, nerve dimension-based method. Regional Anesthesia and Pain Medicine, 34(3):242-246.

Fischer, M D; Huber, G; Beck, S C; Tanimoto, N; Muehlfriedel, R; Fahl, E; Grimm, C; Wenzel, A; Remé, C E; van de Pavert, S A; Wijnholds, J; Pacal, M; Bremner, R; Seeliger, M W (2009). Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography. PLoS ONE, 4(10):e7507.

Huber, G; Arnoux, A; Podvinec, M (2008). Hörverlust nach Bagatelltrauma des Kopfes. Swiss Medical Forum, 80(26-27):504-506.

Glatzel, M; Ott, P M; Linder, T; Gebbers, J O; Gmür, A; Wüst, W; Huber, G; Moch, H; Podvinec, M; Stamm, B; Aguzzi, A (2003). Human prion diseases: epidemiology and integrated risk assessment. Lancet Neurology, 2(12):757-763.

Prinz, M; Huber, G; Macpherson, A J S; Heppner, F L; Glatzel, M; Eugster, H P; Wagner, N; Aguzzi, A (2003). Oral prion infection requires normal numbers of Peyer's patches but not of enteric lymphocytes. American Journal of Pathology, 162(4):1103-1111.

This list was generated on Mon Jul 24 10:11:22 2017 CEST.